SCHEMBL1633466

SCHEMBL1633466

NS(=O)(=O)c1ccc(Nc2ncc3ccc(-c4ccc(NCCN5CCCC5)nc4)cc3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
BRAF P15056 2/20 0.46
CCNT1 O60563 5/20 0.43
CDK1 P06493 5/20 0.43
CCNE1 P24864 5/20 0.43
CDK2 P24941 5/20 0.43
CDK9 P50750 5/20 0.43
CDK5R1 Q15078 5/20 0.43
CDK4 P11802 3/20 0.43
CCNA2 P20248 3/20 0.43
CCND1 P24385 3/20 0.43
CCND3 P30281 3/20 0.43
CDK3 Q00526 3/20 0.43
CDK6 Q00534 3/20 0.43
CDK7 P50613 2/20 0.43
MAP4K1 Q92918 3/20 0.42
PIK3CA P42336 1/20 0.42
SRC P12931 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632319 0.91 BRAF (0.50) CA1CA2CA9BRAFCCNT1
SCHEMBL1633573 0.84 CA1 (0.47) CA1CA2CA9BRAFCCNT1
SCHEMBL1633540 0.84 CA1 (0.47) CA1CA2CA9BRAFCCNT1
SCHEMBL1633149 0.84 CA1 (0.48) CA1CA2CA9CCNT1CDK1
SCHEMBL12764646 0.83 CA1 (0.46) CA1CA2CA9BRAFCCNT1
SCHEMBL1633268 0.81 CA1 (0.44) CA1CA2CA9BRAFCCNT1
SCHEMBL1634288 0.81 CA2 (0.44) CA1CA2CA9BRAFCCNT1
SCHEMBL1631926 0.81 MAP4K1 (0.47) CA1CA2CA9CCNT1CDK1
SCHEMBL1633492 0.80 CDK2 (0.49) CA1CA2CA9CCNT1CDK1
SCHEMBL1634792 0.79 MAPK10 (0.43) CA1CA2CA9CCNT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed